White House Releases FY2022 R&D Budget Priorities
On August 14, White House Office of Management and Budget Director Russ Vought and Office of Science and Technology Policy Director Kelvin Droegemeier released the administration’s FY2022 research and development (R&D) budget priorities. The document outlines the administration’s continued emphasis on biomedical and biotechnology R&D, diagnostic, therapeutic, and vaccine research. For the third straight year, Industries of the Future—artificial intelligence (AI), quantum information science (QIS), and advanced communications networks—are listed as top priorities. Other priorities include targeted federal investments in R&D to preserve and protect American security; harmonized investments in R&D and science and technology (S&T) workforce to ensure the nation’s economic prosperity and national security; and R&D investments that improve research environments that strengthen the security of the U.S. research enterprise, reduce administrative burdens on federally-funded research, improve rigor and integrity in research, and create safe, diverse, inclusive, and equitable research environments for all members of the research enterprise.